Pillstats
Rx only · Capsule, Extended Release · Oral

Methylphenidate Hydrochloride

Brands: Metadate Cd · Ritalin La · Methylphenidate Hydrochloride

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US57 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06BA04
RxCUI (US)6901
US makers11 labelers
Packages57
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 47 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.81$3.61$5.42$7.22Feb 2025Feb 2026Jul 2026
$3.475
Latest avg · Jul 22, 2026
+3%
Since Feb 19, 2025
10
Active US suppliers
26%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

76K152K228K304K2025 Q12025 Q22025 Q32025 Q42026 Q1
236K
Rx · 2026 Q1
7.2M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Rhodes Pharmaceuticals LLCunknown7SUPPLYING
Actavis Pharma, Inc.unknown7SUPPLYING
SpecGx LLCunknown6SUPPLYING
Aytu BioPharma, Inc.unknown6SUPPLYING
Lannett Company, Inc.unknown6SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown6SUPPLYING
Granules Pharmaceuticals Incunknown5SUPPLYING
Dr.Reddy's laboratories Limitedunknown5SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown3SUPPLYING
Mayne Pharma Inc.unknown2SUPPLYING
Novartis Pharmaceuticals Corporationunknown4EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jun 18, 2013
    RECALLRecall (Class II): Methylphenidate Hydrochloride Extended-Release Capsules (LA), 30 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS US…

    Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide

  • Jun 18, 2013
    RECALLRecall (Class II): Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS US…

    Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide

  • Jun 18, 2013
    RECALLRecall (Class II): Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS US…

    Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide